Flaxman A, Marchevsky NG, Jenkin D, Aboagye J, et al. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet 2021 Sep 1. pii: S0140-6736(21)01699.
PMID: 34480858